Search the Newsreel

Beam Therapeutics to present BEAM-302 data at September conference

Beam Therapeutics announced it will present updated clinical data for BEAM-302, its therapy for alpha-1 antitrypsin deficiency, at the European Respiratory Society Congress in September 2026. The therapy uses base editing to correct the PiZ mutation and has shown durable correction and physiological AAT …

Beam Therapeutics to Present BEAM-302 Data at ERS 2026 | BEAM Stock News

Beam Therapeutics (Nasdaq: BEAM) will present updated clinical data from its Phase 1/2 trial of BEAM-302 for alpha-1 antitrypsin deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026 on September 8, 2026. BEAM-302 is a liver-targeting base-editing therapy designed to address both lung …

Beam Therapeutics to Present Updated Data from Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) in Late-Breaking Oral Presentation at the European Respiratory Society (ERS) Congress 2026

Beam logo Beam to Host Investor Webcast to Review BEAM-302 Clinical Data on Tuesday, September 8, 2026, at 7:00 a.m. ET CAMBRIDGE, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, …

Beam Therapeutics to Present Updated Data from Phase 1/2

Beam Therapeutics announced it will present updated clinical data from its Phase 1/2 trial of BEAM-302 for alpha-1 antitrypsin deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026. The company will also host an investor webcast to discuss the data. BEAM-302 is a …

Beam Therapeutics (BEAM) Following Ark Invest Interest And Clinical Milestones Looks Undervalued

Beam Therapeutics (BEAM) is attracting attention due to Ark Invest's increased position and upcoming clinical milestones, including a global BEAM-302 trial. Despite a recent share price pullback, analysts view the stock as significantly undervalued, with a narrative fair value of $51.07 based on its …

Beam Global (BEEM) Stock Price, News, Quote & History

This article provides a detailed financial overview of Beam Global (BEEM), a clean-technology innovation company specializing in renewably energized infrastructure products and battery solutions. It includes current stock price, historical data, key financial metrics, recent news, performance comparisons against the S&P 500, earnings trends, …

Beam Global secures over $0.5M in drone and robotics battery orders within a week

Beam Global has received orders exceeding $0.5 million for specialized batteries from the drone and autonomous robotics sectors within one week. These orders underscore the demand for Beam's advanced batteries, which feature high energy-to-weight ratios, patented safety technologies, and custom designs. The company anticipates …

Beam Global Receives Drone and Autonomous Robotics Battery Orders Exceeding $0.5 Million In a Single Week

Beam Global announced it received over $0.5 million in specialized battery orders from drone and autonomous robotics markets within a single week. The company's battery solutions are valued for their high energy-to-weight ratios, patented thermal management, and bespoke form factors, addressing critical requirements for …

Beamr Imaging Ltd. (BMR) Stock Price, News, Quote & History

This article provides detailed financial information for Beamr Imaging Ltd. (BMR), including its current stock price, historical data, key metrics, and company overview. As of July 23, 2026, the stock closed at $1.18, down 3.28%, with an after-hours price of $1.16. The company, headquartered …

Beamr reports revenue decline in first half of 2026 By Investing.com

Beamr Imaging Ltd. reported a revenue decline for the first half of 2026, with preliminary figures of $0.9 million, down from $1.07 million in the same period of 2025. The company is focusing its video compression technology on autonomous vehicles and Physical AI, having …

Beam Therapeutics Stock 9-Day Losing Spree: Stock Falls 31%

Beam Therapeutics (NASDAQ: BEAM) has experienced a nine-day losing streak, with its stock falling 31% during this period. The article highlights this significant decline in the company's stock performance.

9 Red Days In A Row: Beam Therapeutics Stock Is Down 31%

Beam Therapeutics (BEAM) stock has dropped 31% over nine consecutive trading days, erasing $1.2 billion from its market value. This decline is attributed to the company's significant operating losses, despite strong revenue growth. The article suggests that while losing streaks draw attention, investors should …

Beamr Imaging Ltd. Issues Shareholder Letter Highlighting Autonomous Vehicle and Physical AI Strategy, Preliminary First Half 2026 Revenue Update

Beamr Imaging Ltd. has released a shareholder letter addressing recent share price volatility and outlining its strategy to commercialize its video optimization technology, especially for autonomous vehicles and Physical AI. The company reported preliminary first-half 2026 revenues of $0.9 million, down from $1.07 million …

Beamr Imaging (NASDAQ: BMR) details H1 revenue, cash and AV strategy

Beamr Imaging (NASDAQ: BMR) announced preliminary financial results for H1 2026, reporting approximately $0.9 million in revenue and $7.7 million in cash and cash equivalents. The company is strategically focusing its video compression technology on autonomous vehicles and the broader Physical AI market, aiming …

Drone and robot customers place over $0.5M in Beam orders in one week

Beam Global (Nasdaq: BEEM) announced receiving over $0.5 million in specialized battery orders within a single week from customers in the drone and autonomous robotics markets. These customers chose Beam Global's battery solutions for their high energy-to-weight ratios, bespoke form factors, and proprietary safety …

Beam Global Announces More Than $0.5 Million in Specialized Battery Orders from Drone and Robotics Markets

Beam Global has secured over $0.5 million in specialized battery orders for drone and autonomous robotics markets within a single week, underscoring strong demand for its advanced battery technology. The company's proprietary thermal management system and high energy-to-weight ratio batteries are key differentiators. This …

Heartbeam, Inc. (BEAT) Q4 2023 Earnings Report - Results, Call & Slides

Heartbeam, Inc. (BEAT) announced its Q4 2023 earnings, reporting an actual EPS of $0.07, significantly beating the consensus EPS of -$0.12

ETFs Investing in Beam Therapeutics, Inc. Stocks

This article lists various ETFs that hold stocks of Beam Therapeutics, Inc. The ETFs are sorted by market value and provide details such as weight, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, and NAV total return over three …

Freedom Capital Markets Initiates Beam Global(BEEM.US) With Buy Rating, Announces Target Price $1.5

Freedom Capital Markets has initiated coverage on Beam Global (BEEM.US) with a Buy rating. The firm has set a target price of $1.5 for the company's stock.

Beam Global Q2 prelim revenue exceeds $8.5M

Beam Global announced preliminary Q2 revenue exceeding $8.5 million, marking an over 99% increase compared to Q2 2025. This significant growth is attributed to strong demand and an increase in project wins, particularly for its EV charging and energy storage products. The company plans …

Beam Global เตรียมย้ายฐานการดำเนินงานด้านการผลิตจากรัฐแคลิฟอร์เนียไปยังเมืองยูมา รัฐแอริโซนา

Beam Global (Nasdaq: BEEM) ผู้ผลิตโครงสร้างพื้นฐานสำหรับชาร์จรถยนต์ไฟฟ้าพลังงานแสงอาทิตย์และระบบจัดเก็บพลังงานไฟฟ้า เตรียมย้ายฐานการดำเนินงานด้านการผลิตจากรัฐแคลิฟอร์เนียไปยังเมืองยูมา รัฐแอริโซนา คาดว่าจะเริ่มต้นการดำเนินงานในสถานที่ใหม่ช่วงปลายไตรมาสที่สามของปี 2569 การย้ายฐานครั้งนี้ได้รับการสนับสนุนจากรัฐบาลท้องถิ่นและองค์กรพัฒนาเศรษฐกิจในยูมา เพื่อสร้างงานและเพิ่มรายได้ให้แก่ภูมิภาค

Beamr launches consulting service for autonomous vehicle video compression By Investing.com

Beamr Imaging Ltd. has launched "Beamr Blueprint," a consulting service aimed at helping autonomous vehicle teams implement video compression solutions to manage large datasets. This service, which already has its first engagement, expands Beamr's commercial strategy beyond technology licensing. The company, which maintains a …

Is Beamr Imaging (NASDAQ:BMR) In A Good Position To Invest In Growth?

Beamr Imaging (NASDAQ:BMR), a company that is currently unprofitable, has a cash burn of US$4.7 million and a cash runway of 2.4 years based on its December 2025 balance sheet. While the company's cash burn increased significantly by 113% in the last year, its …

Understanding the Setup: (BEAM) and Scalable Risk

This article analyzes Beam Therapeutics Inc. (NASDAQ: BEAM), noting weak near and mid-term sentiment despite a positive long-term outlook. It highlights that a breakdown is underway with expected lower levels and elevated downside risk. The analysis provides institutional trading strategies for various risk profiles, …

Beam Global Announces Preliminary Second Quarter 2026 Revenue Up More Than 170% From Q1 And More Than 20% Year-Over-Year

Beam Global announced preliminary, unaudited revenue for Q2 2026 exceeded $8.5 million, marking over 170% growth from Q1 2026 and more than 20% year-over-year. This growth is attributed to the diversification of its product portfolio, including drone battery systems, defense applications, and EV charging, …

Beam Therapeutics Stock 6-Day Losing Spree: Stock Falls 19%

Beam Therapeutics (NASDAQ: BEAM) stock has experienced a significant downturn, falling 19% over a six-day losing streak. This article reports on the stock's recent performance.

Beamr launches Blueprint to optimize video compression for autonomous vehicle data, cutting costs and speeding development.

Beamr Imaging Ltd. has introduced "Blueprint," a new service designed to optimize video compression for autonomous vehicle (AV) data. This service helps AV teams manage large volumes of video data by reducing storage and network costs while maintaining model accuracy. A global AV program …

Beamr Launches Blueprint: Fast Track to ML-Safe Compression for Autonomous Vehicle Teams

Beamr Imaging Ltd. has announced Beamr Blueprint, a new expert engagement program designed to help autonomous vehicle (AV) teams quickly and reliably verify the safety of video compression for their specific ML models and workflows. The program is already in use with a global …

Autonomous Vehicle Teams Can Test Compression on Their Own Models

Beamr (NASDAQ: BMR) has launched Beamr Blueprint AV, an expert service designed to help autonomous vehicle (AV) teams determine safe video compression levels for their machine learning models. This service maps AV stacks, tests compression directly on customer data and workflows, and aims to …

Beamr Imaging (NASDAQ: BMR) debuts Blueprint AV compression service

Beamr Imaging Ltd. (NASDAQ: BMR) has launched Beamr Blueprint, a new service designed to help autonomous vehicle (AV) teams safely integrate video compression into their machine-learning workflows. This service involves Beamr's experts mapping AV pipelines, testing compression on customer data and models, and delivering …

Beam Global Reports Preliminary Q2 2026 Revenue Exceeding $8.5 Million, Up More Than 170% Sequentially

Beam Communications Holdings Limited (ASX:BCC): Is the Satellite Technology Sector Putting It in Focus?

BEEM News | BEAM GLOBAL (NASDAQ:BEEM)

Beam Therapeutics (BEAM) Faces New AATD Rival PM647 Ruling What Does It Signal Strategically?

BEEM Q1 2026 Earnings: EPS Miss Overshadowed as Stock Gains on Strategic Momentum - Earnings Trend Analysis

BEEM Forecast — Price Target — Prediction for 2027